Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
225M
-
Shares change
-
-33.6M
-
Total reported value, excl. options
-
$265M
-
Value change
-
-$42.6M
-
Put/Call ratio
-
0.45
-
Number of buys
-
89
-
Number of sells
-
-108
-
Price
-
$1.18
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q1 2025
268 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q1 2025.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 225M shares
of 303M outstanding shares and own 74.35% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (36.5M shares), BlackRock, Inc. (23.5M shares), MADRONE ADVISORS, LLC (23.4M shares), EDMOND DE ROTHSCHILD HOLDING S.A. (21.9M shares), SOFTBANK GROUP CORP. (20.5M shares), VANGUARD GROUP INC (16.3M shares), Sumitomo Mitsui Trust Group, Inc. (9.57M shares), Nikko Asset Management Americas, Inc. (9.57M shares), STATE STREET CORP (6.38M shares), and GEODE CAPITAL MANAGEMENT, LLC (6.32M shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.